Triple negative breast cancer (TNBC), in which cells do not have estrogen (ER-), progesterone (PR-), and HER2 (HER2-) receptors is a highly aggressive breast cancer subtype, responsible for about 20% of breast cancers. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.